About FDA
Percent of Class 1 Recall final press releases approved by OE for posting to the FDA.gov website within 24 hours of receipt
Measure was implemented starting January 2011.
Dictionary: There are many offices involved in the process of posting a firm’s Class 1 recall press release on FDA.gov. A final press release is received by the District and sent to OE for approval and posting. Once OE receives the final press release from the District, it is reviewed by OE and sent to ORA web team for formatting. The formatted version is sent back to OE for approval. Once approved, the ORA web team is notified by OE and posts the press release to FDA.gov. OE will measure the time from OE’s receipt of the final draft from the District until OE notifies the ORA web team of the approval for posting with the goal of 100% completed within 24 hours. The actual posting of the release to the website is not in OE’s control and may be affected by IT issues and therefore will not be included in this timeframe. OE’s goal is to ensure it meets its responsibilities in a timely manner. OE will document the reason(s) for any press releases received and not approved for posting within 24 hours and will take corrective action as needed.
Information is current as of February 12, 2013.
Fiscal Year - 2011
Measure was implemented starting January 2011.
| Time | Target | Percent |
|---|---|---|
| Jan 2011 | 100 | 97 |
| Feb 2011 | 100 | 85 |
| Mar 2011 | 100 | 93 |
| Apr 2011 | 100 | 87 |
| May 2011 | 100 | 93 |
| Jun 2011 | 100 | 93 |
| Jul 2011 | 100 | 100 |
| Aug 2011 | 100 | 100 |
| Sep 2011 | 100 | 100 |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.







